CJC-1295.INFO explains a long-acting growth hormone releasing peptide. We do not sell anything.
CJC-1295
.INFO
Rules & Safety

Legal Status and Safety

At a glance: CJC-1295 is prohibited by name on the WADA list, in and out of competition, and no medicines regulator has authorised it.

Websites and forums sometimes describe CJC-1295 as a gentle, "natural" way to raise growth hormone. Regulators see it as an unapproved drug that was never fully tested.

Sport

The WADA Prohibited List bans growth hormone releasing factors under section S2.2.4. It names GHRH and its analogues and gives CJC-1293, CJC-1295, sermorelin and tesamorelin as examples. Section S2 substances are banned at all times, not only during competition. Doping laboratories have published tests that look for CJC-1295 and its breakdown products, and horse-racing laboratories have developed methods of their own.

Medicines Law

  • European Union: no medicine containing CJC-1295 has a marketing authorisation. Selling it with health claims would fall under medicines rules.
  • United Kingdom: no CJC-1295 product is licensed by the MHRA.
  • United States: CJC-1295 is not an FDA-approved drug.
  • Elsewhere: rules on importing and possessing research peptides differ by country and should be checked locally.

Open Safety Questions

  • Little human data: the published trials involved small groups of healthy volunteers, followed for weeks rather than months.
  • Growth hormone and IGF-I: long-term high levels of these hormones have known effects on blood sugar, fluid balance and tissue growth. Whether a week-long stimulus carries similar risks has not been studied.
  • A long-lasting dose: because CJC-1295 stays active for about a week, its effects cannot be stopped quickly once given.
  • Which molecule? products sold under the name may contain the version without DAC, which behaves differently.
  • Quality: research-grade peptides are not made under pharmaceutical standards, so content and purity can vary.

A Laboratory Reagent

Research-grade CJC-1295 is sold for experiments, not for treatment. It has no approved dose, no patient leaflet and no system for reporting side effects.

In Short

CJC-1295 is interesting to researchers who study the growth hormone system, but it is not a medicine and not a supplement. Athletes face a ban, and anyone considering it for health reasons should speak to a doctor first.

This overview is general information and not legal advice.